We are live on ! Find out more
ANGO icon

AngioDynamics

108 hedge funds and large institutions have $394M invested in AngioDynamics in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

17,138% more call options, than puts

Call options by funds: $4.48M | Put options by funds: $26K

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

29% more capital invested

Capital invested by funds: $305M → $394M (+$88.5M)

19% more funds holding

Funds holding: 91108 (+17)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 37

Holders
108
Holders Change
+17
Holders Change %
+18.68%
% of All Funds
3.12%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
24
Increased
37
Reduced
37
Closed
7
Calls
$4.48M
Puts
$26K
Net Calls
+$4.46M
Net Calls Change
+$4.42M

ANGO Hedge Fund Activity: Q4 2013 in Review

108 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2013, worth a combined $394M — up 29% from $305M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANGO positions and 7 closed out — a net gain of 17 holders — while 37 added to existing stakes and 37 trimmed.

The largest buyer was THB Asset Management, opening a new position worth an estimated $9.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $26.6M sold.

  • 108 institutional investors held AngioDynamics (ANGO) as of Q4 2013, up from 91 in Q3 2013.
  • Funds reported $394M of AngioDynamics stock for Q4 2013, up 29% quarter-over-quarter.
  • 24 funds opened new AngioDynamics positions in Q4 2013 and 7 closed out, a net change of +17 holders.
  • The largest AngioDynamics buyer in Q4 2013 was THB Asset Management, an estimated $9.5M added.
  • The largest AngioDynamics seller in Q4 2013 was Deerfield Management, an estimated $26.6M sold.

Based on aggregated 13F filings for Q4 2013.